Anika Therapeutics (ANIK) Ownership - Who Owns Anika Therapeutics?

176 Followers

Anika Therapeutics (ANIK) Ownership Overview

5.31% Insiders

12.12% Mutual Funds

21.70% Other Institutional Investors

12.00% ETFs

48.87% Public Companies and

Individual Investors

The ownership structure of Anika Therapeutics (ANIK) stock is a mix of institutional, retail, and individual investors. Approximately 45.82% of the company’s stock is owned by Institutional Investors, 5.31% is owned by Insiders, and 48.87% is owned by Public Companies and Individual Investors.

The ownership structure of Anika Therapeutics (ANIK) stock is a mix of institutional, retail, and individual investors. Approximately 33.82% of the company’s stock is owned by Institutional Investors, 5.31% is owned by Insiders, and 12.00% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Diker Management Llc	xxxxxxxxxxxxx	$559398

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
664,305	Institution	4.96%	9,200,624
592,807	Institution	4.42%	8,210,377
477,298	Institution	3.56%	6,610,577
290,876	Institution	2.17%	4,028,633
270,530	Insider	2.02%	3,746,841
144,830	Institution	1.08%	2,005,896
143,378	Institution	1.07%	1,985,785
131,798	Institution	0.98%	1,825,402
129,315	Institution	0.96%	1,791,013
120,658	Institution	0.90%	1,671,113

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
592,807	Institution	4.42%	8,210,377
290,876	Institution	2.17%	4,028,633
144,830	Institution	1.08%	2,005,896
131,798	Institution	0.98%	1,825,402
129,315	Institution	0.96%	1,791,013
70,122	Institution	0.52%	971,190
60,432	Institution	0.45%	836,983
31,845	Institution	0.24%	441,053
30,467	Institution	0.23%	421,968
23,786	Institution	0.18%	329,436

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	428,624	Institution	3.20%	6,155,041
iShares Russell 2000 ETF	286,502	Institution	2.14%	3,968,053
Vanguard Extended Market ETF	164,183	Institution	1.23%	2,357,668
Avantis U.S. Small Cap Value ETF	112,485	Institution	0.84%	1,595,037
iShares Russell 2000 Value ETF	105,206	Institution	0.79%	1,457,103
Schwab U.S. Small-Cap ETF	67,622	Institution	0.50%	958,880
Vanguard Russell 2000 ETF	61,554	Institution	0.46%	883,915
Dimensional U.S. Small Cap ETF	46,777	Institution	0.35%	663,298
iShares Core S&P Total U.S. Stock Market ETF	46,304	Institution	0.35%	656,591
Dimensional US Small Cap Value ETF	36,433	Institution	0.27%	516,620

FAQ

Who Owns Anika Therapeutics (ANIK)?

According to the latest TipRanks data, approximately 21.70% of the company's stock is held by institutional investors, 5.31% is held by insiders, and 48.87% is held by retail investors.

What percentage of Anika Therapeutics (ANIK) stock is held by institutional investors?

According to the latest TipRanks data, approximately 21.70% of Anika Therapeutics (ANIK) stock is held by institutional investors.

What percentage of Anika Therapeutics (ANIK) stock is held by retail investors?

According to the latest TipRanks data, approximately 48.87% of Anika Therapeutics (ANIK) stock is held by retail investors.

Who owns the most shares of Anika Therapeutics (ANIK)?

Vanguard owns the most shares of Anika Therapeutics (ANIK).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.